Literature DB >> 2420955

An immunochemical study with neuron-specific-enolase and substance P of human enteric innervation--the normal developmental pattern and abnormal deviations in Hirschsprung's disease and pyloric stenosis.

P K Tam.   

Abstract

Human enteric innervation was studied immunochemically with neuron-specific-enolase (NSE), a specific neurone marker indicative of differentiation, and substance P, a potent member of the family of neuropeptides. By examining various levels of the gut in 28 normal human fetuses of gestational ages 9 to 21 weeks, we showed that enteric neurones as a whole, as well as peptidergic neurones in particular, followed a dual gradient of development proceeding from each end to the middle of the gut. This suggests the need for caution in accepting the hypothesis of the pathogenesis of Hirschsprung's disease based on the concept of a single craniocaudal gradient of enteric neuronal development. In studies of six infants with Hirschsprung's disease, NSE immunostaining was found to be potentially useful for diagnostic purposes. NSE activity suggested that the hypertrophied nerve bundles in aganglionic bowel were metabolically active and functionally mature. Substance P-immunoreactivity was decreased in both aganglionic and distal ganglionic bowel in Hirschsprung's disease, suggesting that substance P-nerves were more extensively affected developmentally than other enteric neurones. In 28 infants with pyloric stenosis (IHPS), the presence of intense NSE activity in the ganglia in the pylorus suggested that these neurones were neither immature nor severely degenerated. A decrease in substance P immunoreactivity in IHPS suggested possible involvement of peptidergic innervation in the pathogenesis of IHPS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420955     DOI: 10.1016/s0022-3468(86)80840-5

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  11 in total

1.  Myenteric plexus neuropathy in infantile hypertrophic pyloric stenosis.

Authors:  R Dieler; J M Schröder
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Differential expression of MHC- and macrophage-associated antigens in human fetal and postnatal small intestine.

Authors:  J Harvey; D B Jones; D H Wright
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

3.  Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease.

Authors:  A V Emmanuel; M A Kamm
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

4.  Hunterian Lecture. The ontogeny of the peptide innervation of the human pylorus with special reference to understanding the aetiology and pathogenesis of infantile hypertrophic pyloric stenosis.

Authors:  R M Abel
Journal:  Ann R Coll Surg Engl       Date:  2000-11       Impact factor: 1.891

Review 5.  Hirschsprung's disease: clinical and experimental observations.

Authors:  P Puri
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

6.  Infantile hypertrophic pyloric stenosis: myopathic type.

Authors:  R Dieler; J M Schröder; H Skopnik; G Steinau
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 7.  New insights into the pathogenesis of infantile pyloric stenosis.

Authors:  Christina Panteli
Journal:  Pediatr Surg Int       Date:  2009-09-16       Impact factor: 1.827

8.  A novel neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), in human intestine: evidence for reduced content in Hirschsprung's disease.

Authors:  Z Shen; L T Larsson; G Malmfors; A Absood; R Håkanson; F Sundler
Journal:  Cell Tissue Res       Date:  1992-08       Impact factor: 5.249

9.  Fetal development of the pyloric muscle.

Authors:  D Bourdelat; J P Barbet; J P Chevrel
Journal:  Surg Radiol Anat       Date:  1992       Impact factor: 1.246

Review 10.  Development of enteric neuron diversity.

Authors:  Marlene M Hao; Heather M Young
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.